-
May 11, 2023
Time to read: 2 minutes
Otsuka Pharmaceutical and Lundbeck LLC have ...
READ MOREDr Sanil RegeApril 17, 2023Time to read: 13–15 minutes
While newer antidepressant medications have gained popularity in recent years, tricyclic antidepressants (TCAs) remain an essential treatment option for...
READ MOREDr Sanil RegeMarch 21, 2023Time to read: 2 minutes
...
READ MOREDr Sanil RegeMarch 14, 2023Time to read: 9 minutes
For decades, researchers have been investigating the role of muscarinic acetylcholine receptors (mAChRs) in the development an...
READ MOREMarch 9, 2023Time to read: 1 minutes
Treatment options for mental health conditions resistant to treatment are currently limited. ...
READ MOREFebruary 2, 2023Time to read: 1 minutes
Zuranolone is a neurosteroid developed in the treatment of postpartum depression. Neurosteroids or Neuroactive Steroids (NAS) are endogenous ster...
READ MOREDr Sanil RegeJanuary 21, 2023Time to read: 8 minutes
Varenicline (CHANTIX /CHAMPIX) is a nicotinic acetylcholine receptor (nAChR) partial agonist indicated as a smoking cessation drug. ...
READ MOREDecember 19, 2022Time to read: 1 minutes
AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved VRAYLAR® (cariprazine) ; (known as Reagila in Australia) as an adjunctiv...
READ MORE